These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15161067)

  • 21. Mucosal vaccination against diphtheria using starch microparticles as adjuvant for cross-reacting material (CRM197) of diphtheria toxin.
    Rydell N; Sjöholm I
    Vaccine; 2005 Apr; 23(21):2775-83. PubMed ID: 15780725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat.
    Matsuo K; Ishii Y; Quan YS; Kamiyama F; Mukai Y; Yoshioka Y; Okada N; Nakagawa S
    J Control Release; 2011 Jan; 149(1):15-20. PubMed ID: 20493218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K; Goyal AK; Gupta PN; Mishra N; Vyas SP
    Int J Pharm; 2008 Apr; 354(1-2):235-41. PubMed ID: 18182259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The concomitant use of the LTK63 mucosal adjuvant and of chitosan-based delivery system enhances the immunogenicity and efficacy of intranasally administered vaccines.
    Baudner BC; Giuliani MM; Verhoef JC; Rappuoli R; Junginger HE; Giudice GD
    Vaccine; 2003 Sep; 21(25-26):3837-44. PubMed ID: 12922117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae.
    Sabirov A; Kodama S; Sabirova N; Mogi G; Suzuki M
    Vaccine; 2004 Aug; 22(23-24):3112-21. PubMed ID: 15297063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
    Yue Y; Xu W; Hu L; Jiang Z; Xiong S
    Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Toxin-neutralizing properties of antibodies to diphtheria toxin recombinant subunits A and B and a new method of their estimation].
    Kaberniuk AA; Oliĭnyk OS; Kolybo DV; Komisarenko SV
    Ukr Biokhim Zh (1999); 2009; 81(3):92-101. PubMed ID: 19877434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycol chitosan improves the efficacy of intranasally administrated replication defective human adenovirus type 5 expressing glycoprotein D of bovine herpesvirus 1.
    Gogev S; de Fays K; Versali MF; Gautier S; Thiry E
    Vaccine; 2004 May; 22(15-16):1946-53. PubMed ID: 15121307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus.
    Harakuni T; Kohama H; Tadano M; Uechi G; Tsuji N; Matsumoto Y; Miyata T; Tsuboi T; Oku H; Arakawa T
    Jpn J Infect Dis; 2009 Jan; 62(1):37-45. PubMed ID: 19168957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of the infant immune responses by the first pertussis vaccine administrations.
    Mascart F; Hainaut M; Peltier A; Verscheure V; Levy J; Locht C
    Vaccine; 2007 Jan; 25(2):391-8. PubMed ID: 17116347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intranasal priming with HIV DNA vaccine and systemic boosting with recombinant vaccinia induce vigorous immune responses: experiment with mice].
    Huang XG; Xu JQ; Ren L; Qiu C; Zhang N; Liu LX; Wan YM; Peng H; Shao YM
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3109-13. PubMed ID: 17313761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.
    Nochi T; Yuki Y; Katakai Y; Shibata H; Tokuhara D; Mejima M; Kurokawa S; Takahashi Y; Nakanishi U; Ono F; Mimuro H; Sasakawa C; Takaiwa F; Terao K; Kiyono H
    J Immunol; 2009 Nov; 183(10):6538-44. PubMed ID: 19880451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice.
    Nyström-Asklin J; Adamsson J; Harandi AM
    Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intranasal immunization of mice with recombinant lipidated P2086 protein reduces nasal colonization of group B Neisseria meningitidis.
    Zhu D; Barniak V; Zhang Y; Green B; Zlotnick G
    Vaccine; 2006 Jun; 24(26):5420-5. PubMed ID: 16621173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal immunization using biphasic lipid vesicles as delivery systems for OmlA bacterial protein antigen and CpG oligonucleotides adjuvant in a mouse model.
    Alcón VL; Baca-Estrada M; Vega-López MA; Willson P; Babiuk LA; Kumar P; Foldvari M
    J Pharm Pharmacol; 2005 Aug; 57(8):955-62. PubMed ID: 16102250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcutaneous immunization with cross-reacting material CRM(197) of diphtheria toxin boosts functional antibody levels in mice primed parenterally with adsorbed diphtheria toxoid vaccine.
    Stickings P; Peyre M; Coombes L; Muller S; Rappuoli R; Del Giudice G; Partidos CD; Sesardic D
    Infect Immun; 2008 Apr; 76(4):1766-73. PubMed ID: 18227167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats.
    Liu GX; Xu QA; Jin J; Li YH; Jia R; Guo JH; Fan MW
    Vaccine; 2009 May; 27(22):2940-7. PubMed ID: 19428904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine red blood cells as efficient carriers of three bacterial antigens for the production of specific and neutralizing antibodies.
    Polvani C; Gasparini A; Benatti U; DeFlora A; Silvestri S; Volpini G; Nencioni L
    Biotechnol Appl Biochem; 1991 Dec; 14(3):347-56. PubMed ID: 1777119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.